Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine in Brain Death Organ Donors
NCT02211053Phase 4Terminated
- Start
- Jul 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in brain death comparing Levothyroxine with Placebo (2 arms). Primary endpoints: Study feasibility at 2 years and Variation in left ventricular ejection fraction at 6 hours. Started Jul 2014; status: terminated.
02
Drugs
levothyroxine sodium
03
Conditions
brain death
Beyond the preview
Go deeper on NCT02211053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211053.